A Challenging Seven-Year Journey with Drug-Resistant Tuberculosis: Insights for Multidisciplinary Management from a Case Study
-
By
-
Liang Fu
-
Lin Wang
-
Xueyong Bu
-
Yuping Mo
-
Yourou Zheng
-
Guofang Deng
-
January 28, 2026
-
Clinical Scorecard: A Challenging Seven-Year Journey with Drug-Resistant Tuberculosis: Insights for Multidisciplinary Management from a Case Study
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Patients with drug-resistant tuberculosis, particularly young adults with complex pleuropulmonary disease. |
| Care Setting | |
Key Highlights
- Early use of rapid molecular diagnostics is critical for effective treatment.
- Multidisciplinary governance is essential for managing surgery and treatment toxicity.
- Long-term rehabilitation and disability support are necessary beyond microbiological cure.
- Therapeutic drug monitoring is vital for optimizing treatment outcomes.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Careful management of drug side effects, including specific adjustments for neuropathy and other adverse effects, is crucial.
Clinical Best Practices
- Ensure timely and accurate diagnosis to prevent treatment delays.
- Adopt a multidisciplinary approach for comprehensive patient management.
- Focus on rehabilitation and support for patients post-treatment, including monitoring for long-term complications.
References
